Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Inflammatory responses predict long-term mortality risk in community-acquired pneumonia.

Guertler C, Wirz B, Christ-Crain M, Zimmerli W, Mueller B, Schuetz P.

Eur Respir J. 2011 Jun;37(6):1439-46. doi: 10.1183/09031936.00121510. Epub 2010 Nov 11.

2.

Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.

Courtais C, Kuster N, Dupuy AM, Folschveiller M, Jreige R, Bargnoux AS, Guiot J, Lefebvre S, Cristol JP, Sebbane M.

Am J Emerg Med. 2013 Jan;31(1):215-21. doi: 10.1016/j.ajem.2012.07.017. Epub 2012 Sep 20.

PMID:
23000327
3.

Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.

Alan M, Grolimund E, Kutz A, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP study group.

J Intern Med. 2015 Aug;278(2):174-84. doi: 10.1111/joim.12341. Epub 2015 Jan 27.

PMID:
25529395
4.

Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study.

Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ.

Medicine (Baltimore). 2008 Nov;87(6):329-34. doi: 10.1097/MD.0b013e318190f444.

5.

Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.

Lee JH, Kim J, Kim K, Jo YH, Rhee J, Kim TY, Na SH, Hwang SS.

J Crit Care. 2011 Jun;26(3):287-94. doi: 10.1016/j.jcrc.2010.10.007. Epub 2010 Dec 3.

PMID:
21129911
6.

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].

Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B.

Crit Care. 2006;10(3):R96. Epub 2006 Jun 28.

7.

Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.

Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T; CAPNETZ Study Group.

Intensive Care Med. 2007 Dec;33(12):2069-78. Epub 2007 Oct 16.

PMID:
17938883
8.

Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.

Bello S, Lasierra AB, Mincholé E, Fandos S, Ruiz MA, Vera E, de Pablo F, Ferrer M, Menendez R, Torres A.

Eur Respir J. 2012 May;39(5):1144-55. doi: 10.1183/09031936.00080411. Epub 2011 Nov 10.

9.

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.

Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ.

Am J Med. 2005 Apr;118(4):384-92.

PMID:
15808136
10.
11.

Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.

Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T; German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group.

Am J Respir Crit Care Med. 2010 Dec 1;182(11):1426-34. doi: 10.1164/rccm.201003-0415OC. Epub 2010 Jul 16.

PMID:
20639437
12.

Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.

Bello S, Fandos S, Lasierra AB, Mincholé E, Panadero C, Simon AL, Gavin O, De Pablo F, Menendez R, Torres A.

Respir Med. 2015 Sep;109(9):1193-206. doi: 10.1016/j.rmed.2015.07.003. Epub 2015 Jul 14.

PMID:
26205553
13.

Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.

Müller B, Süess E, Schuetz P, Müller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG, Christ-Crain M.

J Intern Med. 2006 Dec;260(6):568-76.

14.

Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia.

Schuetz P, Stolz D, Mueller B, Morgenthaler NG, Struck J, Mueller C, Bingisser R, Tamm M, Christ-Crain M.

BMC Infect Dis. 2008 Feb 28;8:22. doi: 10.1186/1471-2334-8-22.

15.

Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.

Yang Y, Xu F, Shi LY, Diao R, Cheng YS, Chen XY, Jing JY, Wang XD, Shen HH.

Chin Med J (Engl). 2012 Feb;125(4):639-45.

16.

Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.

Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T; CAPNETZ Study Group.

Thorax. 2010 Mar;65(3):208-14. doi: 10.1136/thx.2009.121178.

PMID:
20335288
17.

Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.

Grolimund E, Kutz A, Marlowe RJ, Vögeli A, Alan M, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group.

COPD. 2015 Jun;12(3):295-305. doi: 10.3109/15412555.2014.949002. Epub 2014 Sep 17.

PMID:
25230352
18.

Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community-acquired pneumonia.

Chen CZ, Fan PS, Lin CC, Lee CH, Hsiue TR.

J Formos Med Assoc. 2009 Mar;108(3):219-23. doi: 10.1016/S0929-6646(09)60055-3.

19.

Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia.

Capelastegui A, España PP, Quintana JM, Bilbao A, Menendez R, Zalacain R, Torres A.

Thorax. 2009 Jun;64(6):496-501. doi: 10.1136/thx.2008.098814. Epub 2009 Feb 22.

PMID:
19237392
20.

Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.

Schembri S, Williamson PA, Short PM, Singanayagam A, Akram A, Taylor J, Singanayagam A, Hill AT, Chalmers JD.

BMJ. 2013 Mar 20;346:f1235. doi: 10.1136/bmj.f1235.

Items per page

Supplemental Content

Write to the Help Desk